Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Thrombotic microangiopathy associated with use of interferon-beta.
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review.
Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.
Characterization of CD56bright NK cells in daclizumab HYP-treated RRMS patients
Nephrotic Syndrome in a Multiple Sclerosis Patient Receiving Long-term Interferon Beta Therapy.
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
New Drugs Online report for idebenone
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets.
Alemtuzumab and multiple sclerosis: therapeutic application.
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis.
The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients.
Daclizumab Therapy for Multiple Sclerosis.
Ustekinumab success in refractory Crohn’s disease
Interplay between exercise and dietary fat modulates myelinogenesis in the central nervous system.
Adaptive autoimmunity and Foxp3-based immunoregulation in zebrafish.
New York Academy of Sciences: T Cells at the Interface of Immune-CNS Cross-Talk
GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study.
Adaptive myelination from fish to man.
Ethnicity and prevalence of multiple sclerosis in east London.
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.
Mechanism-based CNS Disease Modeling: Applications in Neurology and Psychiatry Drug Research & Development
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Cognitive impairment in multiple sclerosis.
Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes.
Klotho Is a Neuroprotective and Cognition-Enhancing Protein.
Pages
« first
‹ previous
…
101
102
103
104
105
106
107
108
109
…
next ›
last »